Medifast Incorporated (NYSE:MED) Shorted Shares Decreased By 2.58%

February 15, 2018 - By Richard Conner

 Medifast Incorporated (NYSE:MED) Shorted Shares Decreased By 2.58%

Investors sentiment decreased to 1 in 2017 Q3. Its down 0.11, from 1.11 in 2017Q2. It dropped, as 15 investors sold Medifast, Inc. shares while 60 reduced holdings. 31 funds opened positions while 44 raised stakes. 10.20 million shares or 2.70% less from 10.48 million shares in 2017Q2 were reported.
Amp Capital Invsts Ltd accumulated 4,600 shares. Goldman Sachs Group Inc stated it has 0% in Medifast, Inc. (NYSE:MED). Meeder Asset Mngmt has 0.01% invested in Medifast, Inc. (NYSE:MED). Us Financial Bank De accumulated 689 shares. Legal General Gru Public Ltd Co accumulated 19,180 shares. Renaissance Technologies Ltd Liability Co has invested 0.07% in Medifast, Inc. (NYSE:MED). Arizona State Retirement Sys reported 5,413 shares. Glob X Mngmt Co Limited Liability owns 162 shares for 0% of their portfolio. Moreover, Wedge L Lp Nc has 0.01% invested in Medifast, Inc. (NYSE:MED) for 23,200 shares. 74,337 are held by Morgan Stanley. Kbc Grp Inc Nv has invested 0.01% in Medifast, Inc. (NYSE:MED). Ingalls & Snyder Ltd holds 82,237 shares. Aqr Capital invested in 40,823 shares. Deutsche State Bank Ag has invested 0% in Medifast, Inc. (NYSE:MED). First Citizens Bank & Trust Tru Co owns 3,455 shares or 0.03% of their US portfolio.

The stock of Medifast Incorporated (NYSE:MED) registered a decrease of 2.58% in short interest. MED’s total short interest was 332,100 shares in February as published by FINRA. Its down 2.58% from 340,900 shares, reported previously. With 149,500 shares average volume, it will take short sellers 2 days to cover their MED’s short positions. The short interest to Medifast Incorporated’s float is 3.68%.

The stock increased 0.38% or $0.26 during the last trading session, reaching $69.09. About 68,381 shares traded. Medifast, Inc. (NYSE:MED) has risen 25.81% since February 15, 2017 and is uptrending. It has outperformed by 9.11% the S&P500.

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and diet products. The company has market cap of $824.49 million. The firm offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, eggs, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home, and Essential 1 brands, as well as Dual Fuel, a sports nutrition pilot program. It has a 34.02 P/E ratio. It also provides meal replacements comprising vitamins and minerals; and hydration products, as well as other nutrients for health purposes.

Medifast, Inc. (NYSE:MED) Ratings Coverage

Among 3 analysts covering Medifast (NYSE:MED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Medifast had 7 analyst reports since August 10, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, August 16 by DA Davidson. As per Friday, September 15, the company rating was maintained by DA Davidson. The firm earned “Neutral” rating on Monday, November 30 by Sidoti. Sidoti upgraded Medifast, Inc. (NYSE:MED) on Monday, January 11 to “Buy” rating. On Monday, October 5 the stock rating was upgraded by Sidoti to “Buy”. The stock has “Hold” rating by Zacks on Monday, August 10. The firm has “Hold” rating by Wunderlich given on Friday, January 29.

Another recent and important Medifast, Inc. (NYSE:MED) news was published by which published an article titled: “Medifast, Inc. Announces 50 Percent Increase in Quarterly Dividend” on December 06, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.